GLP-1 Use and Fertility: What Science Says
New reviews explore the intersection of weight loss medication, metabolic health, and pregnancy planning.
Updated on Oct. 14, 2026 in Pregnancy
Live Poll
Do you trust the use of weight-loss medications like GLP-1s to help improve fertility outcomes?
Recent research suggests a link between GLP-1 medications and improved fertility outcomes in women with obesity and polyendocrine metabolic ovarian syndrome. While these findings draw interest, major medical organizations continue to advise against using these drugs while trying to conceive.
Why it matters
Understanding this research is vital for those managing metabolic health while planning pregnancy. Current medical guidance emphasizes safety, as the long-term effects of these medications during early development are not yet fully understood.
A review published in a South American medical journal suggests that weight loss mediated by GLP-1 therapy may improve ovulation and ovarian function. These findings are preliminary and are not currently part of standard clinical fertility protocols.
The players
American College of Obstetricians and Gynecologists
A professional organization that sets standards for obstetric and gynecologic care, including guidance on medication safety during pregnancy.
The details
GLP-1 medications work by targeting hormonal pathways to facilitate weight loss, which in turn helps resolve insulin resistance. By reducing systemic inflammation, these treatments are associated with better ovulation rates and decreased ovarian dysfunction in patients with metabolic syndrome. Despite these potential metabolic benefits, the medications are not currently cleared for use during pregnancy or breastfeeding.
Timeline
Medical guidelines recommend discontinuing GLP-1 usage at least two months prior to attempting conception.
Health Landscape
This research sits in tension with the established American College of Obstetricians and Gynecologists clinical practice guidelines which prioritize caution. While metabolic health is a key driver of fertility, the medical community currently lacks data to support GLP-1 use as a standard fertility treatment.
If you are using GLP-1 medications and planning a pregnancy, it is essential to have a conversation with your physician about your specific timeline. Experts recommend stopping these medications at least two months before attempting to conceive to ensure safety.
The takeaway
While weight loss can support metabolic health and ovulation, safety remains the priority when planning for pregnancy. Discuss the two-month pre-conception medication window with your doctor to coordinate your transition off GLP-1 therapy safely.
Further reading
Learn more about managing your health and family planning in our Pregnancy section.
Source note: This article includes information reported by ABC News.
Live Poll
Do you trust the use of weight-loss medications like GLP-1s to help improve fertility outcomes?
